Sofia Berglund

Sofia Berglund is a Senior Researcher at NEOGAP Therapeutics AB, where responsibilities include overseeing translational and clinical aspects of a first-in-human trial focused on a neoantigen-targeted T cell therapy for solid tumors. Concurrently, Sofia has served as a Medical Doctor at Karolinska Universitetssjukhuset since March 2009 and previously worked as a junior medical doctor in oncology. Past experience includes a postdoctoral fellowship at The Johns Hopkins University School of Medicine researching T cell and cancer cell interactions in acute myeloid leukemia, as well as roles at various medical facilities during medical training, including internships and medical practice in internal medicine. Sofia holds a PhD in Medicine from Karolinska Institutet and a medical degree from the same institution.